44
Views
1
CrossRef citations to date
0
Altmetric
Review

Migraine and restless legs syndrome: current perspectives

, , &
Pages 39-44 | Published online: 15 Dec 2015

References

  • Karroum E, Konofal E, Arnulf I. Karl-Axel Ekbom (1907–1977). J Neurol. 2009;256:683–684.
  • Ekbom KA. Asthenia crurum paraesthetica (‘irritable legs’). A new syndrome consisting of weakness, sensation of cold and nocturnal paraesthesia in the legs, responding to a certain extent to treatment with Priscol and Doryl – a note on paresthesia in general. Acta Med Scand. 1944;118:197–209.
  • Allen RP, Pichietti D, Hening WA, Trenkwaldera C, Walters AS, Montplaisir J. Restless legs syndrome: diagnostic criteria, special considerations, and epidemiology. A report from the restless legs syndrome diagnosis and epidemiology workshop at the National Institutes of Health. Sleep Med. 2003;4(2):101–119.
  • Trenkwalder C, Paulus W, Walters AS. The restless legs syndrome. Lancet Neurol. 2005;4(8):465–475.
  • Merlino G, Valente M, Serafini A, Gigli GL. Restless legs syndrome: diagnosis, epidemiology, classification and consequences. Neurol Sci. 2007;28(1):37–46.
  • Sabayan B, Bagheri M, Haghighi AB. Possible joint origin of restless leg syndrome (RLS) and migraine. Med Hypotheses. 2007;69(1):64–66.
  • Akerman S, Goadsby PJ. Dopamine and migraine: biology and clinical implications. Cephalalgia. 2007;27(11):1308–1314.
  • Cervenka S, Palhagen SE, Comley RA, et al. Support for dopaminergic hypoactivity in restless legs syndrome: a PET study on D2-receptor binding. Brain. 2006;129(8):2017–2028.
  • Bonati MT. Autosomal dominant restless legs syndrome maps on chromosome 14 q. Brain. 2003;126(6):1485–1492.
  • Soragna D. A locus for migraine without aura maps on chromosome 14q 21.2–q 22.3. Am J Hum Genet. 2003;72(1):161–167.
  • Young WB, Piovesan E, Biglan KM. Restless legs syndrome and drug induced akathesia in headache patients. CNS Spectr. 2003;6:450–456.
  • Rhode AM, Hösing VG, Happe S, Biehl K, Young P, Evers S. Comorbidity of migraine and restless legs syndrome – a case-control study. Cephalalgia. 2007;27(11):1255–1260.
  • D’Onofrio F, Bussone G, Cologno D, et al. Restless legs syndrome and primary headaches: a clinical study. Neurol Sci. 2008;29:169–172.
  • Chen PK, Fuh JL, Chen SP, Wang SJ. Association between restless legs syndrome and migraine. J Neurol Neurosurg Psychiatry. 2009;81(5):1–14.
  • Cologno D, Cicarelli G, Petretta V, Onofrio F, Bussone G. High prevalence of dopaminergic premonitory symptoms in migraine patients with restless legs syndrome: a pathogenetic link? Neurol Sci. 2008;29:166–168.
  • Winter AC, Schurks M, Berger K, et al. Migraine and restless legs syndrome in men. Cephalalgia. 2013;33(2):130–135.
  • Schurks M, Winter AC, Berger K, Buring JE, Kurth T. Migraine and restless legs syndrome in women. Cephalalgia. 2012;32(5):382–389.
  • Zanigni S, Giannini G, Pattaro C, et al. Association between restless legs syndrome and migraine: a population-based study. Eur J Neurol. 2014;21(9):1205–1210.
  • Gozubatik-Celik G, Benbir G, Tan F, Karadeniz D, Goksan B. The prevalence of migraine in restless legs syndrome. Headache. 2014; 54(5):872–877.
  • Fernandez-Matarrubia M, Cuadrado ML, Sanchez-Barros CM, et al. Prevalence of migraine in patients with restless legs syndrome: a case-control study. Headache. 2014;54(8):1337–1346.
  • Cannon PR, Larner AJ. Migraine and restless legs syndrome: is there an association? J Headache Pain. 2011;12(4):405–409.
  • Haut SR, Bigal ME, Lipton RB. Chronic disorders with episodic manifestations: focus on epilepsy and migraine. Lancet Neurol. 2006;5:148–157.
  • Becker WJ, Gladstone JP, Aubé M. Migraine prevalence, diagnosis, and disability. Can J Neurol Sci. 2007;34(4):3–9.
  • Rasmussen BK. Epidemiology of headache. Cephalalgia. 2001; 21(7):774–777.
  • Headache Classification Committee of the International Headache Society (IHS). The International Classification of Headache Disorders: 3nd edition. Cephalalgia. 2013;33(9):644–658.
  • Goadsby PJ, Lipton RB, Ferrari MD. Migraine – current understanding and treatment. N Engl J Med. 2002;346(4):257–270.
  • Akerman S, Goadsby PJ. The role of dopamine in a model of trigeminovascular nociception. J Pharmacol Exp Ther. 2005;314(1):162–169.
  • Ifergane G, Buskila D, Simiseshvely N, Zeev K, Cohen H. Prevalence of fibromyalgia syndrome in migraine patients. Cephalalgia. 2006; 26(4):451–456.
  • Breslau N, Lipton RB, Stewart WF, Schultz LR, Welch KM. Comorbidity of migraine and depression: investigating potential etiology and prognosis. Neurology. 2003;60(8):1308–1312.
  • Dahmen N, Kasten M, Wieczorek S, Gencik M, Epplen JT, Ullrich B. Increased frequency of migraine in narcoleptic patients: a confirmatory study. Cephalalgia. 2003;23(1):14–19.
  • Paiva T, Batista A, Martins P, Martins A. The relationship between headaches and sleep disturbances. Headache. 1995;35(10):590–596.
  • Cubo E, Kompoliti K, Leurgans SE, Raman R. Dopaminergic hypersensitivity in patients with Parkinson disease and migraine. Clin Neuropharmacol. 2004;27(1):30–32.
  • Duval C, Norton L. Tremor in patients with migraine. Headache. 2006;46(6):1005–1010.
  • Tan EK, Seah A, See SJ, Lim E, Wong MC, Koh KK. Restless legs syndrome in an Asian population: a study in Singapore. Mov Disord. 2001;16(3):577–579.
  • Sevim S, Dogu O, Camdeviren H, et al. Unexpectedly low prevalence and unusual characteristics of RLS in Mersin, Turkey. Neurology. 2003;61(11):1562–1569.
  • Ferreira KF, Eckeli A, Dach F, Schwalbach MT, Schwalbach J, Speciali JG. Prevalence of restless legs syndrome in patients with chronic pain in Maputo, Mozambique. Sleep Med. 2013;14(12):1417–1418.
  • Eckeli AL, Gitaí LG, Dach F, et al. Prevalence of restless legs syndrome in the rural town of cassia dos coqueiros in Brazil. Sleep Med. 2011; 12(8):762–767.
  • Desautels A, Turecki G, Montplaisir J, et al. Restless legs syndrome: confirmation of linkage to chromosome 12q, genetic heterogeneity, and evidence of complexity. Arch Neurol. 2005;62(4):591–596.
  • Pichler I, Hicks AA, Pramstaller PP. Restless legs syndrome: an update on genetics and future perspectives. Clin Genet. 2008;73(4):297–305.
  • Moore H, Wilkelmann J, Lin L, et al. Periodic leg movements during sleep are associated with polymorphisms in BTBD9, TOX3/BC034767, MEIS1, MAP2K5/SKOR1, and PTPRD. Sleep. 2014;37(9):1535–1542.
  • Earley CJ, Barker PB, Horská A, Allen RP, et al. MRI-determined regional brain iron concentrations in early- and late-onset restless legs syndrome. Sleep Med. 2006;7(5):458–461.
  • Sun ER, Chen CA, Ho G, Earley CJ, Allen RP. Iron and the restless legs syndrome. Sleep. 1998;21(4):371–377.
  • Yucel M, Akgün H, Oz O, Demirkaya S. Migraine and restless leg syndrome co-morbidity may be due to iron deficiency. Ann Indian Acad Neurol. 2013;16(3):461.
  • Gupta R, Spence DW, Bahammam AS, Monti JM, Padi-perumal SR. Association between migraine and restless legs syndrome. Somnologie. 2014;18(2):121–126.
  • Picchietti D, Winkelman JW. Restless legs syndrome, periodic limb movements in sleep, and depression. Sleep. 2005;28(7):891–898.
  • Yunus MB, Aldag JC. Restless legs syndrome and leg cramps in fibromyalgia syndrome: a controlled study. BMJ. 1996;312(7042):1339.
  • Gemignani F, Brindani F, Vitetta F, Marbini A, Calzetti S. Restless legs syndrome in diabetic neuropathy: a frequent manifestation of small fiber neuropathy. J Peripher Nerv Syst. 2007;12(1):50–53.
  • Gemignani F, Brindani F, Negrotti A, Vitetta F, Alfieri S, Marbini A. Restless legs syndrome and polyneuropathy. Mov Disord. 2006; 21(8):1254–1257.
  • Ferreira KS, Eckeli A, Dach F, Speciali JG. Comorbidities, medications and depressive symptoms in patients with restless legs syndrome and migraine. Arq Neuropsiquiatr. 2013;71(2):87–91.
  • Pizzolato R, Villani V, Prosperini L, Ciuffoli A, Sette G. Efficacy and tolerability of pregabalin as preventive treatment for migraine: a 3-month follow-up study. J Headache Pain. 2011;12(5):521–525.
  • Allen R, Chen C, Soaita A, et al. A randomized, double-blind, 6-week, dose-ranging study of pregabalin in patients with restless legs syndrome. Sleep Med. 2010;11(6):512–519.
  • Schürks M, Winter A, Berger K, Kurth T. Migraine and restless legs syndrome: a systematic review. Cephalalgia. 2014;34(10):777–794.
  • Charbit A, Holland PR, Goadsby PJ. Stimulation or lesioning of dopaminergic A11 cell group affects neuronal firing in the trigeminal nucleus caudalis. Cephalalgia. 2007;27:605.
  • Suzuki S, Suzuki K, Myamoto M, et al. Evaluation of contributing factors to restless legs syndrome in migraine patients. J Neurol. 2011;258(11):2026–2035.
  • Varkey E, Cider A, Carlsson J, Linde M. Exercise as migraine prophylaxis: a randomized study using relaxation and topiramate as controls. Cephalalgia. 2011;31(14):1428–1438.
  • Aukerman MM, Aukerman D, Bayard M, et al. Exercise and restless legs syndrome: a randomized controlled trial. J Am Board Fam Med. 2006;19(5):487–493.